Back to search results

MRI for Breast Cancer Detection

This study is comparing Magnetic Resonance Imaging (MRI) with other common imaging methods to see which one is best at finding and defining breast cancer. Researchers want to see if MRI can more accurately identify breast cancer. You may be able to join if you are a woman, at least 21 years old, and have a documented breast exam and mammogram within the last three months. You also need to have breast lesions (abnormal areas) that can be felt or seen on a mammogram. The study aims to enroll 500 participants, but its current status is unclear.

Study design
This is an interventional study comparing MRI to other diagnostic imaging techniques, with a planned enrollment of 500 participants.
What's involved
Participants will undergo one MRI scan. You will also need to have a documented breast physical examination and a mammogram within 3 months of the MRI.
Compensation
Not stated in the trial record.
Follow-up
The primary endpoint is measured at the length of one MRI scan, so follow-up beyond that is not specified.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT01035112

Magnetic Resonance Imaging of Breast Cancer

Recruiting
NAAges 21+InterventionalDiagnostic
Stanford University
~500 participants
Updated 2026-07-01 on ClinicalTrials.gov
What's tested:MRI

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
To compare magnetic resonance imaging (MRI) with more well established diagnostic imaging techniques to determine which method best finds and defines breast cancer.
Measured over Length of one MRI scan

Conditions

Breast Cancer
Breast Cancer Non-invasive Breast Cancer

Explore related trials

Breast CarcinomaInvasive Breast Carcinoma

Where it's being run

1 sites across 1 states
California1

Study leadership

  • Bruce L Daniel · PRINCIPAL_INVESTIGATOR · Stanford University

Who to contact

Jocelyn Steffan
[email protected]
650-725-1812
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Female
Documented breast physical examination,
Documented mammography within 3 months of the MR studies
Palpable or mammographically-detected suspect breast lesions
Women who have already undergone lumpectomy for breast cancer and have post-biopsy/post-radiation changes will be eligible if they have mammographically-detected or palpable breast abnormalities which are sufficiently suspicious to merit core needle or surgical biopsy.

Exclusion

Male by birth
Able to complete the MR examination. Subjects will be interviewed by one of the investigators for the usual contraindications to
MR contraindications including
Pacemakers
Metallic implants
Severe claustrophobia
Aneurysm clips
Pregnancy
Current lactation
Other conditions precluding proximity to a strong magnetic field.
Received an enhanced MR procedure within 48 hours,
Iodinated contrast within six hours,
Known sensitivity to MR contrast agents,
Not likely to complete the study in full or
Other clinical reason which would preclude participation in the protocol.

What this trial measures

  • To compare magnetic resonance imaging (MRI) with more well established diagnostic imaging techniques to determine which method best finds and defines breast cancer.Length of one MRI scan